bibliographicCitation |
Topaly J, Fruehauf S, Ho AD, Zeller WJ. Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning. British Journal of Cancer. 2002 May 07;86(9):1487–93. doi: 10.1038/sj.bjc.6600242. |